Pleomorphic carcinoma of the lung with high serum beta-human chorionic gonadotropin level and gynecomastia

Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2010Yazar
Okutur, KeremHasbal, Barış
Aydın, Kübra
Bozkurt, Mustafa
Namal, Esat
Öz, Büge
Demir, Osman Gökhan
Üst veri
Tüm öğe kaydını gösterKünye
Okutur K, Hasbal B, Aydin K, Bozkurt M, Namal E, Oz B, Kaynak K, Demir G. Pleomorphic carcinoma of the lung with high serum beta-human chorionic gonadotropin level and gynecomastia. Korean Academy of Medical Sciences. 2010; 25(12): 1805-8. doi: 10.3346/jkms.2010.25.12.1805.Özet
INTRODUCTION Pleomorphic carcinoma of the lung is defined as a group of poorly differentiated non-small cell carcinoma that contains a component of sarcoma or sarcoma-like elements and shows carcinomatous as well as spindle and/or giant cell components [1]. Pleomorphic component should comprise at least 10% of neoplasm. It's a rare tumor that makes up only 0.1% to 0.4% of all malignant lung tumors, and its clinical prognosis is highly unpredictable [2-4].Elevated serum beta-human chorionic gonadotropin (βhCG) levels have been reported in 12% of NSCLC patients [5]. When immunohistochemical methods are used, βhCG positivity have been detected in 28% of the resected specimens [5]. Although βhCG production is not seen rarely in NSCLC, clinically significant symptoms, e.g. gynecomastia are uncommon.
Here we describe a 50-yr-old male patient with pulmonary pleomorphic carcinoma producing high levels of βhCG and presenting with gynecomastia.